Go to main content
Important legal notice

EUROPA - Europe's Information Society Thematic Portal


Navigation path: European Commission > Information Society
Language navigation: en

Home | News | Calendar | Library | RSS | XML | Search | Contact | Help


Local menu


Alternate presentations: Default layout Alternate layout, printer-friendly and allows font resizing

Projects :: SafeChemo

SafeChemo: ePrescription and Automation for a Safe Management of Cytostatics

In the critical area of cancer care, healthcare providers are experiencing a growing pressure to improve patient safety and decrease operators� risk, while at the same time working more efficiently and containing costs. The compounding of oncology drugs (cytostatics) is a particularly challenging area, due to the following main factors - high potential for adverse drug events, even when the preparation error is minimal; - significant occupational risk, due to the high toxicity of drugs - rocketing drug budgets. SafeChemo directly addresses these challenges in order to a) increase patient safety, b) lower operators� risk of contamination and c) reduce operating costs. The SafeChemo turn-key approach includes: 1) A series of automation modules: - an e-prescription module, allowing the definition of standard and/or specific protocols, interface to all available clinical data, automated calculation of doses, definition of all prescription details such as speed, route, administration time etc.; - a production scheduling module, which allows processing of all incoming prescription data, dispatching of prescription to multiple machines, organizing production cycles etc. - robotics for the preparation of injectable solutions in a sterile environment, allowing the automated compounding of drugs in final solutions, a highly precise check on drug, dose, volume and other relevant parameters, labeling of final compounded preparations; - a medication administration module, allowing a point-of-care double check of patient and dose to be administered. 2) A validation model to assess: - microbiological safety - precision - performance - cross-contamination - workers� safety - return on investment 3) The reengineering and implementation services to analyze the current cytostatics management circuit and support process change 4) The maintenance and assistance services

Contact information

JUNGER Jean-François
Carl-Braun-Strasse 1
34212 Melsungen
GERMANY
Tel. 00495661711044
Fax. 00495661751044

Participants

Coordinator: B. BRAUN MELSUNGEN AG, GERMANY

Participating partners:

Organisation Country
B. BRAUN MELSUNGEN AG GERMANY
REGION HOVEDSTADENS APOTEK DENMARK
KIVEX A/S DENMARK
MEDARCHIVER SRL ITALY
B.T.C. SRL ITALY
AZIENDA SANITARIA DI BOLZANO ITALY
THE IMPERIAL COLLEGE HEALTHCARE NHS TRUST UNITED KINGDOM

Download as PDF | Permalink


More on this subject

Project ID card
Browse
Quick search
Search all Information Society programme projects:
Home | News | Calendar | Library | RSS | XML | Search | Contact | Help